VFMCRP and Fresenius Kabi will deliver a treatment that will enable patients to remain on RAASi therapy by managing their chronic hyperkalemia... Nov 21
Brink Bilogics licenses bioanalytical testing solution to Fresenius Kabi SwissBioSim GmbH... Sep 11
-Advertisements-